Triple
T12675724
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Kobe Biomedical Innovation Cluster |
E302805
|
entity |
| Predicate | hasPart |
P35
|
FINISHED |
| Object |
Fujisawa Pharmaceutical research facilities
Fujisawa Pharmaceutical research facilities are a major research and development site of the former Fujisawa Pharmaceutical Company, focused on innovative drug discovery and biomedical research within Japan’s life-science sector.
|
E997547
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Fujisawa Pharmaceutical research facilities | Statement: [Kobe Biomedical Innovation Cluster, hasPart, Fujisawa Pharmaceutical research facilities]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Fujisawa Pharmaceutical research facilities Context triple: [Kobe Biomedical Innovation Cluster, hasPart, Fujisawa Pharmaceutical research facilities]
-
A.
Ibuka Laboratory
Ibuka Laboratory was an electronics research workshop in postwar Tokyo that became the foundation for what would later grow into Sony.
-
B.
Mitsubishi Tanabe Pharma
Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
-
C.
Setsunan University Faculty of Pharmacy
Setsunan University Faculty of Pharmacy is the pharmaceutical sciences faculty of Setsunan University in Japan, providing education and research programs for training pharmacists and pharmaceutical researchers.
-
D.
Kamakura Research Laboratories
Kamakura Research Laboratories is a key pharmaceutical research and development facility operated by Chugai Pharmaceutical in Japan.
-
E.
Kyushu University Graduate School of Pharmaceutical Sciences
Kyushu University Graduate School of Pharmaceutical Sciences is a graduate-level institution in Japan dedicated to advanced education and research in pharmaceutical sciences within Kyushu University.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Fujisawa Pharmaceutical research facilities Triple: [Kobe Biomedical Innovation Cluster, hasPart, Fujisawa Pharmaceutical research facilities]
Generated description
Fujisawa Pharmaceutical research facilities are a major research and development site of the former Fujisawa Pharmaceutical Company, focused on innovative drug discovery and biomedical research within Japan’s life-science sector.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Fujisawa Pharmaceutical research facilities Target entity description: Fujisawa Pharmaceutical research facilities are a major research and development site of the former Fujisawa Pharmaceutical Company, focused on innovative drug discovery and biomedical research within Japan’s life-science sector.
-
A.
Ibuka Laboratory
Ibuka Laboratory was an electronics research workshop in postwar Tokyo that became the foundation for what would later grow into Sony.
-
B.
Mitsubishi Tanabe Pharma
Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
-
C.
Setsunan University Faculty of Pharmacy
Setsunan University Faculty of Pharmacy is the pharmaceutical sciences faculty of Setsunan University in Japan, providing education and research programs for training pharmacists and pharmaceutical researchers.
-
D.
Kamakura Research Laboratories
Kamakura Research Laboratories is a key pharmaceutical research and development facility operated by Chugai Pharmaceutical in Japan.
-
E.
Kyushu University Graduate School of Pharmaceutical Sciences
Kyushu University Graduate School of Pharmaceutical Sciences is a graduate-level institution in Japan dedicated to advanced education and research in pharmaceutical sciences within Kyushu University.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d7bdee64a08190801c6d470aefd723 |
completed | April 9, 2026, 2:55 p.m. |
| NER | Named-entity recognition | batch_69d961b0d9c88190a05d6cbcb7a1642d |
completed | April 10, 2026, 8:46 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69f671a163188190b6077c77f9a81681 |
completed | May 2, 2026, 9:50 p.m. |
| NEDg | Description generation | batch_69f672d16f8881908c6d5cfed0b3ec3a |
completed | May 2, 2026, 9:55 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69f67396fdac8190970068b2c39ad2f7 |
completed | May 2, 2026, 9:58 p.m. |
Created at: April 9, 2026, 5:20 p.m.